investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Molecular Signatures of Lethal and Indolent Prostate Cancer
Mark A Rubin
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mark A Rubin
Weill Cornell Medical College
New York, United States
Francesca Demichelis
University of Trento
Trento, Italy
Related projects
Kathryn M Wilson
Bone Metabolism and Bone Metastases in Prostate Cancer
Prostate
Pathology
Robert E Reiter
UCLA SPORE in Prostate Cancer
Prostate
Pathology
Jason S Lewis
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
Prostate
Pathology
Ruth D Etzioni
PROMISS - Prostate Modeling to Identify Surveillance Strategies
Prostate
Pathology
Stephen N Thibodeau
Prostate Cancer Susceptibility: The ICPCG Study
Prostate
Pathology
Rosalynd Denise Upton
Elucidating the Molecular Basis of Metastatic Prostate Cancer Cell Progression
Prostate
Pathology
Hui Zhang
Glycoprotein Biomarkers for the Early Detection of Aggressive Prostate Cancer
Prostate
Pathology
Susan Halabi
Validation of Prognostic and Pathway Signatures in Lethal Prostate Cancer
Prostate
Pathology
Ian M Thompson
San Antonio Center For Biomarkers of Risk for Prostate Cancer (SABOR)
Prostate
Pathology
